Skip to content
value.today
iAnthus Capital Holdings, Inc. logo

iAnthus Capital Holdings, Inc.

IAN.CN
$195 Mlast known market cap, Jan 2024 — no current value
Compare
World rank
—
no current market cap
Revenue
$144 M
For year ending December-2025
Net income
$-40 M
-27.9% margin
SEC filing
Employees
—

iAnthus Capital Holdings, Inc. in brief

iAnthus Capital Holdings, Inc. is a listed company in the Pharmaceutical industry, based in Vancouver, Canada. It was founded in 2013. Its last known market value was $195 M (January 2024); there is no current figure. In the year to December 2025 it had sales of $144 M and a net loss of $40 M. Its largest product and service lines by sales in 2025 were iAnthus branded products (44%), Third party branded products (38%) and Wholesale/bulk/other products (18%).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

iAnthus Capital Holdings, Inc. timeline

1 events, 2013
  1. 2013
  2. 🏁
    · approximate
    Founded

Events of iAnthus Capital Holdings, Inc. from the company record. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$70 M$140 M$210 M$280 M20202021202220232024

World rank over time

▼ down 3,427 places since 2020
2020-01-01: #14620#14,62020202021-01-01: #21854#21,85420212022-01-07: #30273#30,27320222024-01-05: #18047#18,0472024

Rank in Canada: #388 (Jan 2020) · #603 (Jan 2021) · #1,140 (Jan 2022) · #467 (Jan 2024)

Key ratios

market cap and latest results · TTM = trailing 12 months
P/E ratio (TTM)
n/m (loss)
Price / sales (TTM)
—
Price / book
—
Free cash flow yield
—
Net margin (TTM)
-39.3%
Operating margin
-10.7%
Return on equity
—
Liabilities / assets
140.3%
Net debt
$182M
Revenue growth
-14.1%

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Dec 2020: revenue $152M, net income $-313M$152MFY20Fiscal year ending Dec 2021: revenue $203M, net income $-77M$203MFY21Fiscal year ending Dec 2022: revenue $163M, net income $-449M$163MFY22Fiscal year ending Dec 2023: revenue $159M, net income $-77M$159MFY23Fiscal year ending Dec 2024: revenue $168M, net income $-8M$168MFY24Fiscal year ending Dec 2025: revenue $144M, net income $-40M$144MFY25
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Dec 2025$144M-14.1%$-15M$-40M-27.9%
Dec 2024$168M+5.2%$-9M$-8M-4.6%
Dec 2023$159M-2.4%$-30M$-77M-48.1%
Dec 2022$163M-19.6%$-112M$-449M-275.3%
Dec 2021$203M+33.9%$-24M$-77M-38.2%
Dec 2020$152M—$-250M$-313M-206.6%

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Dec 2025$3M$24M$-21M$-0.01—
Dec 2024$13M$6M$7M$0.00—
Dec 2023$4M$4M$0M$-0.01—
Dec 2022$-20M$7M$-26M$-0.13—
Dec 2021$16M$19M$-3M$-0.45—
Dec 2020$-10M$13M$-23M$-1.83—

Quarterly results

USD · three months to · source: SEC filings
Revenue, trailing 12 months
$143M
Net income, trailing 12 months
$-56M
RevenueNet income
Three months to Dec 2024 (from the annual report): revenue $43M, net income $28M$43MDec ’24Three months to Mar 2025: revenue $38M, net income $5M$38MMar ’25Three months to Jun 2025: revenue $35M, net income $-19M$35MJun ’25Three months to Sep 2025: revenue $35M, net income $-13M$35MSep ’25Three months to Dec 2025 (from the annual report): revenue $35M, net income $-14M$35MDec ’25Three months to Mar 2026: revenue $34M, net income $-14M$34MMar ’26Three months to Jun 2026: revenue $35M, net income $-14M$35MJun ’26Three months to Sep 2026: revenue $38M, net income $-13M$38MSep ’26

Latest quarter to Sep 2026: revenue $38M (+8.4% on a year earlier), net income $-13M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.

SEC filings

Official filings of iAnthus Capital Holdings, Inc. with the US Securities and Exchange Commission.

Annual results

Revenue
$144 M
Operating income
$-15 M
Net income
$-40 M

For year ending December-2025 · source: SEC filing

Balance sheet

Total assets
$256 M
Total liabilities
$359 M
Total equity
$-103 M

As of December-2025

Insider trading at iAnthus Capital Holdings, Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$0
0 purchases, 0 insiders
Sold, 12 months
$0
0 sales, 0 insiders
Net, 12 months
$0
open market only
Insiders on file
1
since
iAnthus Capital Holdings, Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Jason Matthew WareCFOGrant or award+78.95 M——78.95 MForm 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

iAnthus Capital Holdings, Inc. scorecard#

Passes 3 of the 15 checks that could be worked out: strongest in profitability (1 of 4), weakest in growth (1 of 6). Fiscal year 2025.

  • Valuationnot known
    • –P/E below its peers' medianNo market cap.
    • –Price to book below its peers' medianNo market cap.
    • –Price to sales below its peers' medianNo market cap.
    • –Free cash flow yield above 5%No market cap.
    • –Earnings yield above the 10-year Treasury yieldNo market cap.
    • –The price assumes slower growth than the last three years'No market cap.
  • Growth1 of 6
    • ✗Revenue grew in the newest year-14.1%Revenue down 14.1% in fiscal 2025.
    • ✗Revenue up more than 5% a year over three years-4.1%-4.1% a year over the three years to fiscal 2025.
    • ✗Faster growth over three years than its peers' median-4.1%-4.1% a year against Pharmaceutical's median of 2.5% (65 companies).
    • ✗Earnings per share grew in the newest year-0.01 vs 0.00Diluted EPS -0.01 in fiscal 2025 against 0.00 the year before (report's currency).
    • ✓Net income higher than five years earlier-$40 M-$40 M in fiscal 2025 against -$313 M in 2020.
    • ✗Revenue rose in at least four of the last five years2 of 5Revenue rose in 2 of the five years to fiscal 2025.
  • Profitability1 of 4
    • ✗Profitable in the newest year-$40 MNet income -$40 M in fiscal 2025.
    • ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2025.
    • ✗Operating margin above its peers' median-10.7%-10.7% against Pharmaceutical's median of 1.8% (74 companies).
    • –Return on equity above 15%No return on equity (equity missing or negative).
    • –Return on invested capital above 10%No return on invested capital on file.
    • ✓Operating margin wider than three years earlier-10.7%-10.7% in fiscal 2025 against -68.9% in 2022.
  • Financial health1 of 4
    • ✗Short-term assets cover short-term liabilities0.7×Current ratio 0.71 at the end of fiscal 2025.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • ✗Net debt below three years of EBITDA47.1×Net debt 47.1 times EBITDA in fiscal 2025.
    • ✗Operating income covers interest five times-0.9×Operating income -0.9 times interest in fiscal 2025.
    • ✓Cash from operations positive in each of the last three years3 of 3Positive in 3 of the three years to fiscal 2025.
    • –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
  • Shareholder returns0 of 1
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • ✗Share count up no more than 2% in a year2.5%Diluted shares up 2.5% in fiscal 2025.
    • –Dividends and buybacks above 3% of the market valueNo market cap.
    • –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.

Worked out from the statements as filed (sec), the medians of Pharmaceutical, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Financial analysis, 2025#

Worked out from iAnthus Capital Holdings, Inc.'s statements, beside the median of Pharmaceutical.

iAnthus Capital Holdings, Inc.: main financial ratios in 2025
Ratio2025Median of peers
Operating margin-10.7%1.8%
Net margin-27.9%-1.5%
Revenue growth, 3 years a year-4.1%2.5%
Revenue growth-14.1%7.3%
Free cash flow margin-14.3%6.0%

3of 9on the Piotroski tests of financial strength

  • Revenue fell 14.1% against the year before.
  • Net loss of $40 million, the 6th loss-making year in a row.
  • Free cash flow was negative: -$21 million.
  • Shareholders' equity is negative: -$103 million.

iAnthus Capital Holdings, Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

iAnthus Capital Holdings, Inc.: statements by fiscal year
PeriodTrendFY 2025to Dec 31, 2025FY 2024to Dec 31, 2024FY 2023to Dec 31, 2023FY 2022to Dec 31, 2022FY 2021to Dec 31, 2021FY 2020to Dec 31, 2020
Income statement
Revenue144168159163203152
Cost of revenue7892968993r70
Gross profit66756374110r82
Selling, general and administrative616268r1289798
Operating expenses818493r187133332
Total costs and expenses———01.90
Operating income−15−8.5−30r−112−24r−250
Interest and finance income———0.10.50.4
Interest expense and finance costs17171619r1.73.4
Share of profit of associates−0.0−0.2−0.2000.2
Income before tax−23−25−49r−439−56r−295
Income tax17−1827r1122r19
Net income including minority interests——77———
Net income attributable to shareholders−40−7.6−77−449−77r−313
Earnings per share, basic-0.010.00-0.01-0.13-0.45r-1.83
Earnings per share, diluted-0.010.00-0.01-0.13-0.45r-1.83
Shares, weighted average (basic)6,7026,5406,437r3.40.2—
Shares, weighted average (diluted)6,7026,5406,437r3.40.2r172
Balance sheet
Cash and cash equivalents121913141311
Receivables6.45.54.64.03.63.4
Inventory2222253029r25
Other current assets4.61.60.20.21.61.7
Current assets4975465154r46
Property, plant and equipment1058794103113107
Right-of-use (leased) assets292427283033
Goodwill1.66.10000
Other intangible assets6773105117139159
Long-term investments0.80.90.70.20.60.5
Total assets256271277303345r353
Accounts payable161314111412
Debt due within a year00.10.10.1165157
Current liabilities697512593285r232
Long-term debt1941821651472814
Lease liabilities (non-current)272228292828
Total liabilities359337339292369r306
Retained earnings−1,375−1,335−1,328−1,251−802r−724
Shareholders' equity−103−66−6211−24r47
Total liabilities and equity256271277303345r353
Shares outstanding6,8596,6786,511r6.4r172172
Cash-flow statement
Depreciation and amortization192527313128
Share-based compensation1.82.14.5306.512
Cash from operating activities3.1133.8r−1916−9.8
Capital expenditure−24−5.5−3.6−6.9−19−13
Intangible assets bought−0.1−0.2−2.5−0.1−1.0−0.8
Cash from investing activities2.3−6.3−4.4r−4.7−21−15
Debt issued——0241115
Debt repaid−7.4−0.1−0.0−0.4−0.1−11
Cash from financing activities−13−0.3−0.622101.3
Change in cash−7.25.9−1.2−2.25.1−23
Report10-K10-K10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

What iAnthus Capital Holdings, Inc. sells: revenue by product line, fiscal 2025#

As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.

Products and services

  • iAnthus branded products$63 M44%
  • Third party branded products$55 M38%
  • Wholesale/bulk/other products$26 M18%

Business segments

  • Eastern Region$134 M93%
  • Western Region$10 M7.2%

Source: SEC annual report (XBRL data) · as of Dec 31, 2025

Where iAnthus Capital Holdings, Inc. operates: 2 countries#

Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue. 1 subsidiaries on file.

iAnthus Capital Holdings, Inc.: countries of operation
CountryPresenceRevenue there
🇨🇦 CanadaHeadquarters—
🇱🇺 Luxembourg1 subsidiary—

Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided

Events at iAnthus Capital Holdings, Inc.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

Warning signs in the last three years

  • Auditor changedFiling
  • Financial statements withdrawnFiling

Financial statements withdrawn 1 · Auditor changed 1 · Acquisition or sale completed 1 · Directors and officers 4 · Material agreement 1 · Shareholder vote 3 · Results announced 11

iAnthus Capital Holdings, Inc.: events reported to the SEC
FiledWhat happenedFiling
Auditor changedResults announced8-K
Results announced8-K
Shareholder vote8-K
Results announced8-K
Directors and officers8-K
Results announced8-K
Acquisition or sale completed8-K
Results announced8-K
Shareholder vote8-K
Results announced8-K
Results announced8-K
Results announced8-K
Material agreement8-K
Directors and officers8-K
Results announced8-K
Shareholder vote8-K
Results announced8-K
Directors and officers8-K
Results announced8-K
Directors and officers8-K
Financial statements withdrawn8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Nov 12, 2026

Acquisitions and funding#

1 acquisitions, $6 M paid where reported · 5 private funding rounds before listing

Businesses it acquired

Acquisitions by iAnthus Capital Holdings, Inc.
AcquiredAcquisition dateCompletionPriceStakeSource
Cheetah Enterprises, Inc2025—$6 M—Annual report

Private share sales · funding history

Private share sales of iAnthus Capital Holdings, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2019$27 MNo. 5$10 to $50 million3debt, optionsSEC
May 2018$40 MNo. 4$10 to $50 million2debt, optionsSEC
Apr 2018$4 MIssued in a merger or acquisition$2 to $10 million8equitySEC
Feb 2018$13 MIssued in a merger or acquisition$10 to $50 million57equitySEC
Jan 2018$20 MNo. 3$10 to $50 million1debt, optionsSEC
Nov 2017$2 MNo. 2$2 to $10 million20equitySEC
Nov 2016$1 MNo. 1Under $2 million27equity, optionsSEC
Aug 2016$9 MIssued in a merger or acquisition$2 to $10 million8equitySEC

Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.

How iAnthus Capital Holdings, Inc. compares in Pharmaceutical

  • Revenue$144 M · higher than 24% of 324
  • Net margin-39.3% · higher than 8% of 313
  • Revenue growth-14.1% · higher than 10% of 107

Peer comparison · Pharmaceutical

CompanyMarket capP/ENet marginRev. growth
iAnthus Capital Holdings, Inc.🇨🇦$195 M—-39.3%-14.1%
Eli Lilly and Company🇺🇸$1.20 T43.4×31.9%+44.7%
Johnson & Johnson🇺🇸$652.5 B40.5×16.2%+6.0%
AbbVie Inc.🇺🇸$514.0 B49.7×15.7%+8.6%
Roche Holding AG🇨🇭$370.3 B29.1×19.0%—
Merck & Co., Inc.🇺🇸$359.8 B146.7×3.6%+1.3%
Novartis AG🇨🇭$286.8 B20.5×24.7%—
Amgen Inc.🇺🇸$249.2 B26.5×24.1%+9.9%
AstraZeneca PLC🇬🇧$242.6 B23.7×17.4%+8.6%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jan 5, 2024 (last known)
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Profile updated:
Nov 16, 2026

Figures from SEC filing, value.today research; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at iAnthus Capital Holdings, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show iAnthus Capital Holdings, Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about iAnthus Capital Holdings, Inc.? Suggest a correction